Given its central role in both neuroplasticity and metabolic regulation, altered BDNF levels have also been implicated in the pathophysiology of obstructive sleep apnea (OSA), which manifests as the repetitive cessation of breathing during sleep due to airway collapse, categorized as hypopneas or apneas. This evidence concerns the gene BDNF and obstructive sleep apnea syndrome.